Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-12-05

Clinical Trial Update: Dupilumab Therapy in Nephrotic Syndrome in Children [Phase 2]

View source ↗

Summary

The document describes a Phase 2 clinical trial evaluating dupilumab for nephrotic syndrome in children, including steroid-dependent nephrotic syndrome, which i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dupilumab (dupilumab)

Snippet

Sponsor: National University Hospital, Singapore | Conditions: Nephrotic Syndrome in Children, Nephrotic Syndrome Steroid-Dependent | Phase 2 | Status: RECRUITING